Exact Mass: 305.1176

Exact Mass Matches: 305.1176

Found 167 metabolites which its exact mass value is equals to given mass value 305.1176, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Zanthodioline

3,4-dihydroxy-7-methoxy-2,2,6-trimethyl-2H,3H,4H,5H,6H-pyrano[3,2-c]quinolin-5-one

C16H19NO5 (305.1263)


Zanthodioline is found in fruits. Zanthodioline is an alkaloid from the bark of Zanthoxylum simulans (Szechuan pepper

   

Ciprofloxacin-7-ethylenediamine

7-[(2-aminoethyl)amino]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

C15H16FN3O3 (305.1176)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones

   

6-Fluoro-1-methyl-1,4-dihydro-7-(1-piperazinyl)-4-oxoquinoline-3-carboxylic acid

6-fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid

C15H16FN3O3 (305.1176)


   

m-Hydroxybenzoylecgonine

8-Azabicyclo[3.2.1]octane-2-carboxylic acid, 3-[(3-hydroxybenzoyl)oxy]-8-methyl-, (1R,2R,3S,5S)-

C16H19NO5 (305.1263)


   

N-Hydroxynorcocaine

methyl 3-(benzoyloxy)-8-hydroxy-8-azabicyclo[3.2.1]octane-2-carboxylate

C16H19NO5 (305.1263)


   

p-hydroxybenzoylecgonine

3-(4-hydroxybenzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid

C16H19NO5 (305.1263)


   

Diethyl 5-oxo-3-phenylpyrrolidine-2,2-dicarboxylate

2,2-Diethyl 5-hydroxy-3-phenyl-3,4-dihydro-2H-pyrrole-2,2-dicarboxylic acid

C16H19NO5 (305.1263)


   

Pentoprilat

1-(4-carboxy-2,4-dimethylbutanoyl)-2,3-dihydro-1H-indole-2-carboxylic acid

C16H19NO5 (305.1263)


   

Rohitukine

5,7-dihydroxy-8-(3-hydroxy-1-methylpiperidin-4-yl)-2-methyl-4H-chromen-4-one

C16H19NO5 (305.1263)


   

(1R,2R,3S,5S)-3-Hydroxy-4-(4-hydroxybenzoyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid

(1R,2R,3S,5S)-3-Hydroxy-4-(4-hydroxybenzoyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid

C16H19NO5 (305.1263)


   

(1R,2R,3S,5S)-3-Hydroxy-4-(3-hydroxybenzoyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid

(1R,2R,3S,5S)-3-Hydroxy-4-(3-hydroxybenzoyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid

C16H19NO5 (305.1263)


   

Rohitukine

Rohitukine

C16H19NO5 (305.1263)


A member of the class of chromones that is 4H-chromen-4-one in which the hydrogens at positions 2,5,7 and 8 are replaced by methyl, hydroxy, hydroxy, and (3S,4R)-3-hydroxy-1-methylpiperidin-4-yl groups, respectively. It is an alkaloid initially isolated from Amoora rohituka and is a precursor of the anti-cancer compound flavopiridol.

   

Passiguatemalin

Passiguatemalin

C12H19NO8 (305.1111)


   

(-)-Nitropeptin

(-)-Nitropeptin

C11H19N3O7 (305.1223)


   
   
   

Pancratinine D

Pancratinine D

C16H19NO5 (305.1263)


   

R-Benzodiazepinedione

R-Benzodiazepinedione

C18H15N3O2 (305.1164)


   

(2S,4R)-2-Carboxy-4-(E)-p-coumaroyloxy-1,1-dimethylpyrrolidinium inner salt

(2S,4R)-2-Carboxy-4-(E)-p-coumaroyloxy-1,1-dimethylpyrrolidinium inner salt

C16H19NO5 (305.1263)


   

m-Hydroxybenzoylecgonine

m-Hydroxybenzoylecgonine

C16H19NO5 (305.1263)


   

Metazachlor BH 479-11

Metazachlor BH 479-11

C15H19N3O2S (305.1198)


CONFIDENCE standard compound; INTERNAL_ID 2650

   

UNII-6LUU9T79QN

UNII-6LUU9T79QN

C16H19NO5 (305.1263)


   

3alpha-vanillyl-N-formylnortropane|confolidine

3alpha-vanillyl-N-formylnortropane|confolidine

C16H19NO5 (305.1263)


   

MCULE-2231490264

MCULE-2231490264

C16H19NO5 (305.1263)


   
   

1,5-Dihydro-1-[1-oxo-3-(3,4,5-trimethoxyphenyl)propyl]-2H-pyrrol-2-one

1,5-Dihydro-1-[1-oxo-3-(3,4,5-trimethoxyphenyl)propyl]-2H-pyrrol-2-one

C16H19NO5 (305.1263)


   
   

L-alanyl-L-homoserinyl-L-aspartic acid

L-alanyl-L-homoserinyl-L-aspartic acid

C11H19N3O7 (305.1223)


   

SCHEMBL10832629

SCHEMBL10832629

C18H15N3O2 (305.1164)


   
   

SCHEMBL16164835

SCHEMBL16164835

C16H19NO5 (305.1263)


   

8-(4-O-methyl-alpha-ribopyranosyloxy)-2-methylquinoline

8-(4-O-methyl-alpha-ribopyranosyloxy)-2-methylquinoline

C16H19NO5 (305.1263)


   

2,3,5,6,8,9-Hexahydro-1,5,7-triazaspiro[acephenanthrylene-10(7H),1-[2,5]-cyclohexadiene]-6,4-dione

2,3,5,6,8,9-Hexahydro-1,5,7-triazaspiro[acephenanthrylene-10(7H),1-[2,5]-cyclohexadiene]-6,4-dione

C18H15N3O2 (305.1164)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Desethyleneciprofloxacin

7-(2-aminoethylamino)-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid

C15H16FN3O3 (305.1176)


   

N-Hydroxynorcocaine

N-Hydroxynorcocaine

C16H19NO5 (305.1263)


   
   

Zanthodioline

3,4-dihydroxy-7-methoxy-2,2,6-trimethyl-2H,3H,4H,5H,6H-pyrano[3,2-c]quinolin-5-one

C16H19NO5 (305.1263)


   

Pyrido[2,3-b][1,6]naphthyridine, 6,7,8,9-tetrahydro-7-(2-hydroxybenzoyl)- (9CI)

Pyrido[2,3-b][1,6]naphthyridine, 6,7,8,9-tetrahydro-7-(2-hydroxybenzoyl)- (9CI)

C18H15N3O2 (305.1164)


   

3-(2-CARBOXY-ACETYL)-PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER

3-(2-CARBOXY-ACETYL)-PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER

C16H19NO5 (305.1263)


   

methyl 2-(oxan-4-ylidene)-2-(phenylmethoxycarbonylamino)acetate

methyl 2-(oxan-4-ylidene)-2-(phenylmethoxycarbonylamino)acetate

C16H19NO5 (305.1263)


   

N-Ethyl-N-(4-methoxybenzyl)benzenesulfonamide

N-Ethyl-N-(4-methoxybenzyl)benzenesulfonamide

C16H19NO3S (305.1086)


   

(S)-(-)-N-(3-PENTYL)-1-PHENYLETHYLAMINEHYDROCHLORIDE

(S)-(-)-N-(3-PENTYL)-1-PHENYLETHYLAMINEHYDROCHLORIDE

C16H19NO3S (305.1086)


   

N-(4-(Benzyloxy)benzylidene)-4-fluoroaniline

N-(4-(Benzyloxy)benzylidene)-4-fluoroaniline

C20H16FNO (305.1216)


   

(3R,4S)-1-tert-Butoxycarbonyl-3-acetoxy-4-phenyl-2-azetidinone

(3R,4S)-1-tert-Butoxycarbonyl-3-acetoxy-4-phenyl-2-azetidinone

C16H19NO5 (305.1263)


   
   

benzyl 1-(2-methoxy-2-oxoacetyl)piperidine-2-carboxylate

benzyl 1-(2-methoxy-2-oxoacetyl)piperidine-2-carboxylate

C16H19NO5 (305.1263)


   
   

1-[2-[(2-HYDROXYETHYL)THIO]ETHYL]-2-METHYL-5-PHENYL-1H-PYRROLE-3-CARBOXYLIC ACID

1-[2-[(2-HYDROXYETHYL)THIO]ETHYL]-2-METHYL-5-PHENYL-1H-PYRROLE-3-CARBOXYLIC ACID

C16H19NO3S (305.1086)


   

Dribendazole

Dribendazole

C15H19N3O2S (305.1198)


C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent

   

Ethyl (S)-2-[(S)-4-methyl-2,5-dioxo-1,3-oxazolidin-3-yl]-4-phenylbutyrate

Ethyl (S)-2-[(S)-4-methyl-2,5-dioxo-1,3-oxazolidin-3-yl]-4-phenylbutyrate

C16H19NO5 (305.1263)


   

Bzl-L-Phe-OMe * HCl

Bzl-L-Phe-OMe * HCl

C17H20ClNO2 (305.1182)


   

VU 0357121

VU 0357121

C17H17F2NO2 (305.1227)


VU 0357121 is a positive and highly selective mGlu5R allosteric modulator (PAM) with an EC50 of 33 nM. VU 0357121 is inactive or very weakly antagonizing at other mGlu receptor subtypes[1].

   

Tetrahydro-2,2-dimethyl-4,7-methano-6H-1,3-dioxolo[4,5-d][1,2]oxazine-6-carboxylic acid phenylmethyl ester

Tetrahydro-2,2-dimethyl-4,7-methano-6H-1,3-dioxolo[4,5-d][1,2]oxazine-6-carboxylic acid phenylmethyl ester

C16H19NO5 (305.1263)


   

N-(1-(2-Methoxyphenyl)ethyl)-4-MethylbenzenesulfonaMide

N-(1-(2-Methoxyphenyl)ethyl)-4-MethylbenzenesulfonaMide

C16H19NO3S (305.1086)


   

N-(1-(3-Methoxyphenyl)ethyl)-4-MethylbenzenesulfonaMide

N-(1-(3-Methoxyphenyl)ethyl)-4-MethylbenzenesulfonaMide

C16H19NO3S (305.1086)


   

6,7-dimethoxy-1-phenyl-1,2,3,4-tetrahydro-isoquinoline

6,7-dimethoxy-1-phenyl-1,2,3,4-tetrahydro-isoquinoline

C17H20ClNO2 (305.1182)


   

4-Nitro-N,N-diphenyl-1,3-benzenediamine

4-Nitro-N,N-diphenyl-1,3-benzenediamine

C18H15N3O2 (305.1164)


   

1-Methyl-4-(4-methylpiperidin-4-yl)piperazine trihydrochloride

1-Methyl-4-(4-methylpiperidin-4-yl)piperazine trihydrochloride

C11H26Cl3N3 (305.1192)


   
   

1-Benzyl 3-ethyl 4-oxopiperidine-1,3-dicarboxylate

1-Benzyl 3-ethyl 4-oxopiperidine-1,3-dicarboxylate

C16H19NO5 (305.1263)


   

Diethyl 5-oxo-3-phenylpyrrolidine-2,2-dicarboxylate

Diethyl 5-oxo-3-phenylpyrrolidine-2,2-dicarboxylate

C16H19NO5 (305.1263)


   

Thiazole orange cation

Thiazole orange cation

C19H17N2S+ (305.1112)


   

2-({[2-(Methoxycarbonyl)phenyl]amino}carbonyl)cyclohexanecarboxylic acid

2-({[2-(Methoxycarbonyl)phenyl]amino}carbonyl)cyclohexanecarboxylic acid

C16H19NO5 (305.1263)


   

N-(2-furanylmethyl)-3-(2-furanylmethylimino)-1-isoindolamine

N-(2-furanylmethyl)-3-(2-furanylmethylimino)-1-isoindolamine

C18H15N3O2 (305.1164)


   

gamma-Glutamyl-threoninyl-glycine

gamma-Glutamyl-threoninyl-glycine

C11H19N3O7 (305.1223)


   

(R)-benzodiazepinedione

(R)-benzodiazepinedione

C18H15N3O2 (305.1164)


   

(1R,2R,3S,5S)-3-Hydroxy-4-(4-hydroxybenzoyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid

(1R,2R,3S,5S)-3-Hydroxy-4-(4-hydroxybenzoyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid

C16H19NO5 (305.1263)


   

(1R,2R,3S,5S)-3-Hydroxy-4-(3-hydroxybenzoyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid

(1R,2R,3S,5S)-3-Hydroxy-4-(3-hydroxybenzoyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid

C16H19NO5 (305.1263)


   

(3s)-3-(1h-Indol-3-Ylmethyl)-3,4-Dihydro-1h-1,4-Benzodiazepine-2,5-Dione

(3s)-3-(1h-Indol-3-Ylmethyl)-3,4-Dihydro-1h-1,4-Benzodiazepine-2,5-Dione

C18H15N3O2 (305.1164)


   

2-[(2,3-Dihydro-1,4-benzodioxin-6-ylamino)-oxomethyl]-1-cyclohexanecarboxylic acid

2-[(2,3-Dihydro-1,4-benzodioxin-6-ylamino)-oxomethyl]-1-cyclohexanecarboxylic acid

C16H19NO5 (305.1263)


   

7-Methoxy-2-(3-methoxyanilino)-3-quinolinecarbonitrile

7-Methoxy-2-(3-methoxyanilino)-3-quinolinecarbonitrile

C18H15N3O2 (305.1164)


   

N-[5-(4-tert-butylphenyl)-1,3,4-thiadiazol-2-yl]-2-methoxyacetamide

N-[5-(4-tert-butylphenyl)-1,3,4-thiadiazol-2-yl]-2-methoxyacetamide

C15H19N3O2S (305.1198)


   

N-(3-Ethynylphenyl)-6,7-dimethoxy-4-quinazolinamine

N-(3-Ethynylphenyl)-6,7-dimethoxy-4-quinazolinamine

C18H15N3O2 (305.1164)


   

N-(1,3-benzothiazol-2-yl)-2-(2,6-dimethyl-4-morpholinyl)acetamide

N-(1,3-benzothiazol-2-yl)-2-(2,6-dimethyl-4-morpholinyl)acetamide

C15H19N3O2S (305.1198)


   

5-(1,4-Diazepan-1-ylsulfonyl)-4-methylisoquinoline

5-(1,4-Diazepan-1-ylsulfonyl)-4-methylisoquinoline

C15H19N3O2S (305.1198)


   

3-(1,3-Dihydrobenzimidazol-2-ylidene)-1-ethylquinoline-2,4-dione

3-(1,3-Dihydrobenzimidazol-2-ylidene)-1-ethylquinoline-2,4-dione

C18H15N3O2 (305.1164)


   

Thr-Ala-Asp

Thr-Ala-Asp

C11H19N3O7 (305.1223)


A tripeptide composed of L-threonine, L-alanine, and L-aspartic acid joined by peptide linkages.

   

N-(2-ethylphenyl)-2-methoxy-5-methylbenzenesulfonamide

N-(2-ethylphenyl)-2-methoxy-5-methylbenzenesulfonamide

C16H19NO3S (305.1086)


   

N-(4-hydroxy-2-methyl-5-propan-2-ylphenyl)benzenesulfonamide

N-(4-hydroxy-2-methyl-5-propan-2-ylphenyl)benzenesulfonamide

C16H19NO3S (305.1086)


   

5-Acetyloxy-2-[[cyclohexyl(oxo)methyl]amino]benzoic acid

5-Acetyloxy-2-[[cyclohexyl(oxo)methyl]amino]benzoic acid

C16H19NO5 (305.1263)


   

1,3-Dimethyl-6-(1-naphthalenyl)pyrrolo[3,4-d]pyrimidine-2,4-dione

1,3-Dimethyl-6-(1-naphthalenyl)pyrrolo[3,4-d]pyrimidine-2,4-dione

C18H15N3O2 (305.1164)


   

(1-Allyl-1H-benzoimidazol-2-yl)-benzo[1,3]dioxol-5-ylmethylene-amine

(1-Allyl-1H-benzoimidazol-2-yl)-benzo[1,3]dioxol-5-ylmethylene-amine

C18H15N3O2 (305.1164)


   

2-(4-Ethyl-piperazin-1-yl)-5-(5-methyl-furan-2-ylmethylene)-thiazol-4-one

2-(4-Ethyl-piperazin-1-yl)-5-(5-methyl-furan-2-ylmethylene)-thiazol-4-one

C15H19N3O2S (305.1198)


   

2,5-Dimethyl-4-(4-methyl-1-piperidinyl)-6-thieno[2,3-d]pyrimidinecarboxylic acid

2,5-Dimethyl-4-(4-methyl-1-piperidinyl)-6-thieno[2,3-d]pyrimidinecarboxylic acid

C15H19N3O2S (305.1198)


   

N-[2-(1-pyrrolidinyl)ethyl]-8-quinolinesulfonamide

N-[2-(1-pyrrolidinyl)ethyl]-8-quinolinesulfonamide

C15H19N3O2S (305.1198)


   
   
   
   
   
   
   

2-[(2S,3S,6R)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

2-[(2S,3S,6R)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

C16H19NO5 (305.1263)


   

2-[(2S,3R,6R)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

2-[(2S,3R,6R)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

C16H19NO5 (305.1263)


   

2-[(2R,3S,6R)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

2-[(2R,3S,6R)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

C16H19NO5 (305.1263)


   

2-[(2S,3S,6S)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

2-[(2S,3S,6S)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

C16H19NO5 (305.1263)


   

2-[(2R,3S,6S)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

2-[(2R,3S,6S)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

C16H19NO5 (305.1263)


   

2-[(2S,3R,6S)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

2-[(2S,3R,6S)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

C16H19NO5 (305.1263)


   

2-[(2R,3R,6S)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

2-[(2R,3R,6S)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

C16H19NO5 (305.1263)


   

2-[(2R,3R,6R)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

2-[(2R,3R,6R)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

C16H19NO5 (305.1263)


   
   
   
   
   
   
   
   
   
   
   
   

(E)-nesocodin (oxo-form)

(E)-nesocodin (oxo-form)

C16H19NO5 (305.1263)


   

(E)-nesocodin (alcohol-form)

(E)-nesocodin (alcohol-form)

C16H19NO5 (305.1263)


   

1-[(E)-3-(3,5-dimethoxy-4-oxocyclohexa-2,5-dien-1-ylidene)prop-1-enyl]pyrrolidine-2-carboxylic acid

1-[(E)-3-(3,5-dimethoxy-4-oxocyclohexa-2,5-dien-1-ylidene)prop-1-enyl]pyrrolidine-2-carboxylic acid

C16H19NO5 (305.1263)


   

FPTQ

FPTQ

C17H12FN5 (305.1077)


FPTQ is potent mGluR1 antagonist with IC50 values of 6 nM and 1.4 nM for human and mouse mGluR1 respectively[1]. FPTQ has anti-oxidant and anti-inflammatory effects in vitro and in vivo[2].

   

GN44028

GN44028

C18H15N3O2 (305.1164)


GN44028 is a potent and orally active hypoxia inducible factor (HIF)-1α inhibitor, with an IC50 of 14 nM. GN44028 inhibits hypoxia-induced HIF-1α transcriptional activity without suppressing HIF-1α mRNA expression, HIF-1α protein accumulation, or HIF-1α/HIF-1β heterodimerization. GN44028 can be used in the research of cancers[1][3].

   

N-Propargyladenosine

N-Propargyladenosine

C13H15N5O4 (305.1124)


N-Propargyladenosine is an adenosine analogue. Adenosine analogs mostly act as smooth muscle vasodilators and have also been shown to inhibit cancer progression. The popular products in this series are adenosine phosphate, Acadesine (HY-13417), Clofarabine (HY-A0005), Fludarabine phosphate (HY-B0028) and Vidarabine (HY-B0277)[1]. N-Propargyladenosine is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

   

(2e)-3-(6,7-dimethoxy-2h-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)prop-2-en-1-one

(2e)-3-(6,7-dimethoxy-2h-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)prop-2-en-1-one

C16H19NO5 (305.1263)


   

(1s,15r,17r,18s,19r)-17,18-dihydroxy-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-2,4(8),9-trien-12-ium-12-olate

(1s,15r,17r,18s,19r)-17,18-dihydroxy-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-2,4(8),9-trien-12-ium-12-olate

C16H19NO5 (305.1263)


   

1-[2-(4-hydroxyphenyl)ethyl]-5-[(1s,2r)-1,2,3-trihydroxypropyl]pyrrole-2-carbaldehyde

1-[2-(4-hydroxyphenyl)ethyl]-5-[(1s,2r)-1,2,3-trihydroxypropyl]pyrrole-2-carbaldehyde

C16H19NO5 (305.1263)


   

(1r,13s,16s,17r)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-triene-13,16,17-triol

(1r,13s,16s,17r)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-triene-13,16,17-triol

C16H19NO5 (305.1263)


   

methyl 4-methyl-6-(1,4,6-trihydroxy-3h-isoindol-5-yl)hex-3-enoate

methyl 4-methyl-6-(1,4,6-trihydroxy-3h-isoindol-5-yl)hex-3-enoate

C16H19NO5 (305.1263)


   

2-({2-[(2-amino-1-hydroxypropylidene)amino]-1,4-dihydroxybutylidene}amino)butanedioic acid

2-({2-[(2-amino-1-hydroxypropylidene)amino]-1,4-dihydroxybutylidene}amino)butanedioic acid

C11H19N3O7 (305.1223)


   

(2s,4r)-2-carboxy-4-(e)-p-coumaroyloxy-1,1-dimethylpyrrolidinium inner salt

NA

C16H19NO5 (305.1263)


{"Ingredient_id": "HBIN006744","Ingredient_name": "(2s,4r)-2-carboxy-4-(e)-p-coumaroyloxy-1,1-dimethylpyrrolidinium inner salt","Alias": "NA","Ingredient_formula": "C16H19NO5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "3166","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

methyl 4-methyl-6-(1,4,6-trihydroxy-3h-isoindol-5-yl)hex-4-enoate

methyl 4-methyl-6-(1,4,6-trihydroxy-3h-isoindol-5-yl)hex-4-enoate

C16H19NO5 (305.1263)


   

(1r,2s,3r)-2,3-dihydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopentane-1-carbonitrile

(1r,2s,3r)-2,3-dihydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopentane-1-carbonitrile

C12H19NO8 (305.1111)


   

(3r,4s)-3,4-dihydroxy-7-methoxy-2,2,6-trimethyl-3h,4h-pyrano[3,2-c]quinolin-5-one

(3r,4s)-3,4-dihydroxy-7-methoxy-2,2,6-trimethyl-3h,4h-pyrano[3,2-c]quinolin-5-one

C16H19NO5 (305.1263)


   

(2s)-2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-3-nitropentanedioic acid

(2s)-2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-3-nitropentanedioic acid

C11H19N3O7 (305.1223)


   

(3s)-3-(1h-indol-3-ylmethyl)-3h-1,4-benzodiazepine-2,5-diol

(3s)-3-(1h-indol-3-ylmethyl)-3h-1,4-benzodiazepine-2,5-diol

C18H15N3O2 (305.1164)


   

methyl (3e)-4-methyl-6-(1,4,6-trihydroxy-3h-isoindol-5-yl)hex-3-enoate

methyl (3e)-4-methyl-6-(1,4,6-trihydroxy-3h-isoindol-5-yl)hex-3-enoate

C16H19NO5 (305.1263)


   

(4r,5r,6e,8e,11r)-4-methyl-2-azabicyclo[10.3.1]hexadeca-1(15),2,6,8,12(16),13-hexaene-3,5,11,14,16-pentol

(4r,5r,6e,8e,11r)-4-methyl-2-azabicyclo[10.3.1]hexadeca-1(15),2,6,8,12(16),13-hexaene-3,5,11,14,16-pentol

C16H19NO5 (305.1263)


   

4-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carboximidic acid

4-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carboximidic acid

C12H19NO8 (305.1111)


   

5,7-dihydroxy-8-[(3r,4s)-3-hydroxy-1-methylpiperidin-4-yl]-2-methylchromen-4-one

5,7-dihydroxy-8-[(3r,4s)-3-hydroxy-1-methylpiperidin-4-yl]-2-methylchromen-4-one

C16H19NO5 (305.1263)


   

(3s,4r)-3,4-dihydroxy-7-methoxy-2,2,6-trimethyl-3h,4h-pyrano[3,2-c]quinolin-5-one

(3s,4r)-3,4-dihydroxy-7-methoxy-2,2,6-trimethyl-3h,4h-pyrano[3,2-c]quinolin-5-one

C16H19NO5 (305.1263)


   

3-(1h-indol-3-ylmethyl)-3h-1,4-benzodiazepine-2,5-diol

3-(1h-indol-3-ylmethyl)-3h-1,4-benzodiazepine-2,5-diol

C18H15N3O2 (305.1164)


   

5-methoxy-2-[(2-methylquinolin-8-yl)oxy]oxane-3,4-diol

5-methoxy-2-[(2-methylquinolin-8-yl)oxy]oxane-3,4-diol

C16H19NO5 (305.1263)


   

10-{[(1e)-2-(4-hydroxyphenyl)ethenyl]amino}-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,7,9-tetraen-11-one

10-{[(1e)-2-(4-hydroxyphenyl)ethenyl]amino}-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,7,9-tetraen-11-one

C18H15N3O2 (305.1164)


   

10-{[(1e)-2-(4-hydroxyphenyl)ethenyl]amino}-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),2,4(12),7,9-pentaen-11-ol

10-{[(1e)-2-(4-hydroxyphenyl)ethenyl]amino}-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),2,4(12),7,9-pentaen-11-ol

C18H15N3O2 (305.1164)


   

(2s,3s)-2-amino-3-{[(2e)-3-[2-(3-methyloxiran-2-yl)phenyl]prop-2-enoyl]oxy}butanoic acid

(2s,3s)-2-amino-3-{[(2e)-3-[2-(3-methyloxiran-2-yl)phenyl]prop-2-enoyl]oxy}butanoic acid

C16H19NO5 (305.1263)


   

(1s,4s)-4-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carboximidic acid

(1s,4s)-4-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carboximidic acid

C12H19NO8 (305.1111)


   

methyl 5-{3h,4h,9h-pyrido[3,4-b]indol-1-yl}pyridine-3-carboxylate

methyl 5-{3h,4h,9h-pyrido[3,4-b]indol-1-yl}pyridine-3-carboxylate

C18H15N3O2 (305.1164)


   

(1r,4r)-4-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carboximidic acid

(1r,4r)-4-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carboximidic acid

C12H19NO8 (305.1111)


   

3-[3-(3,4-dimethoxyphenyl)propanoyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one

3-[3-(3,4-dimethoxyphenyl)propanoyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one

C16H19NO5 (305.1263)


   

(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-1,4-dihydroxybutylidene]amino}butanedioic acid

(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-1,4-dihydroxybutylidene]amino}butanedioic acid

C11H19N3O7 (305.1223)


   

(1r,6r)-3-[3-(3,4-dimethoxyphenyl)propanoyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one

(1r,6r)-3-[3-(3,4-dimethoxyphenyl)propanoyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one

C16H19NO5 (305.1263)


   

1-hydroxy-5-methoxy-6-methyl-7-[(3-methylbut-2-en-1-yl)oxy]-3h-isoindole-4-carboxylic acid

1-hydroxy-5-methoxy-6-methyl-7-[(3-methylbut-2-en-1-yl)oxy]-3h-isoindole-4-carboxylic acid

C16H19NO5 (305.1263)


   

1-[2-(4-hydroxyphenyl)ethyl]-5-(1,2,3-trihydroxypropyl)pyrrole-2-carbaldehyde

1-[2-(4-hydroxyphenyl)ethyl]-5-(1,2,3-trihydroxypropyl)pyrrole-2-carbaldehyde

C16H19NO5 (305.1263)


   

methyl (4e)-4-methyl-6-(1,4,6-trihydroxy-3h-isoindol-5-yl)hex-4-enoate

methyl (4e)-4-methyl-6-(1,4,6-trihydroxy-3h-isoindol-5-yl)hex-4-enoate

C16H19NO5 (305.1263)